Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |